Syncom Formulations (India) Limited
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and su… Read more
Syncom Formulations (India) Limited (SYNCOMF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.007x
Based on the latest financial reports, Syncom Formulations (India) Limited (SYNCOMF) has a cash flow conversion efficiency ratio of 0.007x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹17.58 Million) by net assets (₹2.70 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Syncom Formulations (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Syncom Formulations (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Syncom Formulations (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Syncom Formulations (India) Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CONPET SA
RO:COTE
|
N/A |
|
OptiNose
NASDAQ:OPTN
|
-0.027x |
|
TAIGA BUILDING PRODS
F:4T7
|
N/A |
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
0.023x |
|
Daejoo Inc
KQ:003310
|
0.035x |
|
Yesco Holdings Co. Ltd
KO:015360
|
-0.068x |
|
Grazziotin S.A
SA:CGRA3
|
0.065x |
|
Simply Better Brands Corp.
OTCQB:SBBCF
|
-0.473x |
Annual Cash Flow Conversion Efficiency for Syncom Formulations (India) Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Syncom Formulations (India) Limited from 2006 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹3.42 Billion | ₹234.36 Million | 0.068x | +430.29% |
| 2024-03-31 | ₹2.87 Billion | ₹-59.58 Million | -0.021x | -150.42% |
| 2023-03-31 | ₹2.56 Billion | ₹105.29 Million | 0.041x | -44.03% |
| 2022-03-31 | ₹2.22 Billion | ₹163.29 Million | 0.073x | +791.44% |
| 2021-03-31 | ₹1.88 Billion | ₹-19.93 Million | -0.011x | -206.10% |
| 2020-03-31 | ₹1.46 Billion | ₹-5.06 Million | -0.003x | -110.64% |
| 2019-03-31 | ₹1.33 Billion | ₹43.29 Million | 0.033x | +348.68% |
| 2018-03-31 | ₹1.22 Billion | ₹-16.01 Million | -0.013x | -111.13% |
| 2017-03-31 | ₹1.17 Billion | ₹138.41 Million | 0.118x | -46.97% |
| 2016-03-31 | ₹1.09 Billion | ₹241.74 Million | 0.222x | +11832.06% |
| 2015-03-31 | ₹1.00 Billion | ₹1.87 Million | 0.002x | -97.36% |
| 2014-03-31 | ₹951.99 Million | ₹67.30 Million | 0.071x | +7.30% |
| 2013-03-31 | ₹877.09 Million | ₹57.79 Million | 0.066x | -14.20% |
| 2012-03-31 | ₹836.08 Million | ₹64.20 Million | 0.077x | +281.55% |
| 2011-03-31 | ₹816.58 Million | ₹-34.54 Million | -0.042x | -381.24% |
| 2010-03-31 | ₹550.47 Million | ₹-4.84 Million | -0.009x | +51.59% |
| 2009-03-31 | ₹411.32 Million | ₹-7.47 Million | -0.018x | -112.90% |
| 2008-03-31 | ₹390.34 Million | ₹54.94 Million | 0.141x | -0.43% |
| 2007-03-31 | ₹342.37 Million | ₹48.40 Million | 0.141x | +69.71% |
| 2006-03-31 | ₹292.59 Million | ₹24.37 Million | 0.083x | -- |